We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The study was paused in September after reports surfaced of reduced leaflet motion observations in patients implanted with transcatheter aortic valve devices. Read More
The company received complaints that distinguishing the smooth from rough surface of the device proved difficult, which could lead to major adverse events. Read More
The device provides individualized insulin recommendations and allows patients to be transferred from intravenous to subcutaneous treatments as needed. Read More